Trends in Research on Patients With COVID-19 in Korean Medical Journals
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study was conducted to systematically summarize trends in research concerning patients with coronavirus disease 2019 (COVID-19) as reported in Korean medical journals.Methods: We performed a literature search of KoreaMed from January 2020 to September 2022. We included only primary studies of patients with COVID-19. Two reviewers screened titles and abstracts, then performed full-text screening, both independently and in duplicate. We first identified the 5 journals with the greatest numbers of eligible publications, then extracted data pertaining to the general characteristics, study population attributes, and research features of papers published in these journals.Results: Our analysis encompassed 142 primary studies. Of these, approximately 41.0% reported a funding source, while 3.5% disclosed a conflict of interest. In 2020, 42.9% of studies included fewer than 10 participants; however, by 2022, the proportion of studies with over 200 participants had increased to 40.6%. The most common design was the cohort study (48.6%), followed by case reports/series (35.2%). Only 3 randomized controlled trials were identified. Studies most frequently focused on prognosis (58.5%), followed by therapy/intervention (20.4%). Regarding the type of intervention/exposure, therapeutic clinical interventions comprised 26.1%, while studies of morbidity accounted for 13.4%. As for the outcomes measured, 50.7% of studies assessed symptoms/clinical status/improvement, and 14.1% evaluated mortality.Conclusions: Employing a systematic approach, we examined the characteristics of research involving patients with COVID-19 that was published in Korean medical journals from 2020 onward. Subsequent research should assess not only publication trends over a longer timeframe but also the quality of evidence provided.
Abstract
Objectives: This study was conducted to systematically summarize trends in research concerning patients with coronavirus disease 2019 (COVID-19) as reported in Korean medical journals.Methods: We performed a literature search of KoreaMed from January 2020 to September 2022. We included only primary studies of patients with COVID-19. Two reviewers screened titles and abstracts, then performed full-text screening, both independently and in duplicate. We first identified the 5 journals with the greatest numbers of eligible publications, then extracted data pertaining to the general characteristics, study population attributes, and research features of papers published in these journals.Results: Our analysis encompassed 142 primary studies. Of these, approximately 41.0% reported a funding source, while 3.5% disclosed a conflict of interest. In 2020, 42.9% of studies included fewer than 10 participants; however, by 2022, the proportion of studies with over 200 participants had increased to 40.6%. The most common design was the cohort study (48.6%), followed by case reports/series (35.2%). Only 3 randomized controlled trials were identified. Studies most frequently focused on prognosis (58.5%), followed by therapy/intervention (20.4%). Regarding the type of intervention/exposure, therapeutic clinical interventions comprised 26.1%, while studies of morbidity accounted for 13.4%. As for the outcomes measured, 50.7% of studies assessed symptoms/clinical status/improvement, and 14.1% evaluated mortality.Conclusions: Employing a systematic approach, we examined the characteristics of research involving patients with COVID-19 that was published in Korean medical journals from 2020 onward. Subsequent research should assess not only publication trends over a longer timeframe but also the quality of evidence provided.
참고문헌 (25)
- "Coronavirus (COVID-19), Republic of Korea"[URL]
- "WHO COVID-19 dashboard"[URL]
- Chu DT, "COVID-19 in Southeast Asia : current status and perspectives", Bioengineered, 13(2), pp.3797~3809 (2022)[DOI]
- Tu H, "Exploring COVID-19 transmission patterns and key factors during epidemics caused by three major strains in Asia", J Theor Biol, 557, pp.111336~ (2023)[DOI]
- Nham E, "COVID-19 vaccination in Korea : past, present, and the way forward", J Korean Med Sci, 37(47), pp.e351~ (2022)[DOI]
- Parohan M, "Risk factors for mortality in patients with coronavirus disease 2019(COVID-19)infection : a systematic review and meta-analysis of observational studies", Aging Male, 23(5), pp.1416~1424 (2020)[DOI]
- Siemieniuk RA, "Drug treatments for COVID-19 : living systematic review and network meta-analysis", BMJ, 370, pp.m2980~ (2020)[DOI]
- "Update to living WHO guideline on drugs for COVID-19", BMJ, 378, pp.o2224~ (2022)[DOI]
- Abali H, "Prognostic predictors for mortality of patients with COVID-19 in an intensive care unit", J Infect Dev Ctries, 16(10), pp.1555~1563 (2022)[DOI]
- Raez LE, "Mortality and prognostic factors in hospitalized COVID-19 patients with cancer : an analysis from a large healthcare system in the United States", Ann Transl Med, 10(20), pp.1090~ (2022)[DOI]
- Walle-Hansen MM, "Health-related quality of life, functional decline, and long-term mortality in older patients following hospitalisation due to COVID-19", BMC Geriatr, 21(1), pp.199~ (2021)[DOI]
- Lee CH, "COVID-19 literature published in emergency medicine journals in 2020", West J Emerg Med, 23(3), pp.432~438 (2022)[DOI]
- Khalifa AA, "How fast is the peer-review process for orthopaedic publications related to the Covid-19 pandemic?", J Clin Orthop Trauma, 12(1), pp.9~15 (2021)[DOI]
- Li Y, "Reporting and methodological quality of COVID-19 systematic reviews needs to be improved : an evidence mapping", J Clin Epidemiol, 135, pp.17~28 (2021)[DOI]
- Chen Y, "Epidemiology, methodological quality, and reporting characteristics of systematic reviews and meta-analyses on coronavirus disease 2019 : a cross-sectional study", Medicine(Baltimore), 100(47), pp.e27950~ (2021)[DOI]
- Jones RC, "Evaluating trends in COVID-19 research activity in early 2020 : the creation and utilization of a novel open-access database", Cureus, 12(8), pp.e9943~ (2020)[DOI]
- Gurnani B, "Analysis of COVID-19 publications in the Indian Journal of Ophthalmology during two years of the pandemic and their impact on ophthalmic literature", Indian J Ophthalmol, 70(5), pp.1522~1532 (2022)[DOI]
- Sofi-Mahmudi A, "Transparency of COVID-19-related research in dental journals", Front Oral Health, 3, pp.871033~ (2022)[DOI]
- Kim JM, "Analysis of PubMed and KoreaMed indexed Korean publications on COVID-19", J Korean Med Sci, 36(49), pp.e345~ (2021)[DOI]
- Low WY, "Trend and impact of international collaboration in clinical medicine papers published in Malaysia", Scientometrics, 98(2), pp.1521~1533 (2014)[DOI]
- Leydesdorff L, "The relative influences of government funding and international collaboration on citation impact", J Assoc Inf Sci Technol, 70(2), pp.198~201 (2019)[DOI]
- Lundh A, "Industry sponsorship and research outcome", Cochrane Database Syst Rev, 2(2), pp.MR000033~ (2017)[DOI]
- von Elm E, "The Strengthening the Reporting of Observational Studies in Epidemiology(STROBE)statement : guidelines for reporting observational studies", J Clin Epidemiol, 61(4), pp.344~349 (2008)[DOI]
- Schulz KF, "CONSORT 2010 statement : updated guidelines for reporting parallel group randomised trials", BMJ, 340, pp.c332~ (2010)[DOI]
- Devereaux PJ, "The evolution of the randomized controlled trial and its role in evidence-based decision making", J Intern Med, 254(2), pp.105~113 (2003)[DOI]